Document is current
Any future updates will be listed below
-
Authors
Tuesley, Karen M. https://orcid.org/0000-0002-5944-5085
Webb, Penelope M. https://orcid.org/0000-0003-0733-5930
Protani, Melinda M. https://orcid.org/0000-0001-6452-7571
Donovan, Peter https://orcid.org/0000-0001-7934-601X
Jordan, Susan J. https://orcid.org/0000-0002-4566-1414
Dixon-Suen, Suzanne https://orcid.org/0000-0003-3714-8386
-
Funding
Funding for this research was provided by:
Australian Government (Research Training Program scholarship)
National Health and Medical Research Council (GNT1173346)
The University of Queensland
- License Information
-
More Information
Article History
Received: 4 March 2024
Accepted: 29 September 2024
First Online: 18 October 2024
Declarations
:
: PW has received grant funding from AstraZeneca for an unrelated study of ovarian cancer and a speaker’s fee from AstraZeneca (November 2021).
: The study was approved by the Human Research Ethics Committees of the University of Queensland.
: The analyses use de-identified publicly available data from consortiums who obtained informed consent from participants.
